Optimizing Study Design for Clinically Useful Peripheral Molecular Biomarker Discovery in Psychiatry

JAMA Psychiatry · Published 2026-08-05 · DOI 10.1001/jamapsychiatry.2026.2299

Authors (4)

Chloe X. Yap, Anjali K. Henders, Naomi R. Wray, Rachel Upthegrove

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yap, C., Henders, A., Wray, N., et al. (2026). Optimizing Study Design for Clinically Useful Peripheral Molecular Biomarker Discovery in Psychiatry. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2026.2299

Related articles

• Error in Table · JAMA Psychiatry · 2026 · Same journal
• Medication and Procedural Abortion and Risk of Psychotropic Medication Use · JAMA Psychiatry · 2026 · Same journal
• Assessing Drug Efficacy After Multiple Negative Trials—Gepirone’s Journey Through the FDA · JAMA Psychiatry · 2026 · Same journal
• Electroencephalography Microstates—A Biomarker for Psychosis? · JAMA Psychiatry · 2026 · Same journal
• Deconstructing Social Functioning in Psychosis Risk—From Prediction to Recovery · JAMA Psychiatry · 2026 · Same journal
• Confounding and Circularity in Actigraphy Prediction · JAMA Psychiatry · 2026 · Same journal
• Psychedelics Trials and Outcomes—A Closer Look—Reply · JAMA Psychiatry · 2026 · Same journal
• JAMA Psychiatry · JAMA Psychiatry · 2026 · Same journal
• Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression · JAMA Psychiatry · 2026 · Same journal
• Error in Visual Abstract · JAMA Psychiatry · 2026 · Same journal